-
-
-
-
-
-
-
Raymond James Reiterates Strong Buy Rating on Rapport Therapeutics (RAPP)
-
-
-
-
-
-
-
Rapport Therapeutics (RAPP) Reiterated at Market Outperform by Citizens on RAP-219 Data
-
-
-
-
-
-
-
Rapport Therapeutics' (RAPP) RAP-219 is Best-in-Class - Citizens
-
-
-
-
-
-
-
Rapport Therapeutics (RAPP) PT Raised to $56 at Stifel
-
-
-
-
-
-
-
Jones Trading Reiterates Buy Rating on Rapport Therapeutics (RAPP)
-
-
-
-
-
-
-
TD Cowen: '10 Potential "Thome Run" Catalysts to Watch in 2025'
-
-
-
-
-
459,686 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

